(3aS,4S,7S,7aR)-7,8,8-trimethylhexahydro-4,7-methanobenzo[d]oxazol-2(3H)-one
(3aS,4S,7S,7aR)-7,8,8-trimethylhexahydro-4,7-methanobenzo[d]oxazol-2(3H)-one

(3aS,4S,7S,7aR)-7,8,8-trimethylhexahydro-4,7-methanobenzo[d]oxazol-2(3H)-one

FOB
MOQ:
1 g
Shipping:
Express Delivery
Product details
Essential details
MOQ:1 g
Lead time:4 weeks
Shipping:Express Delivery
Product Introduction
A pharmaceutical intermediate specifically developed for the synthesis of active pharmaceutical ingredients (APIs) and key drug intermediates. It offers high purity and structural stability, catering to R&D and industrial applications in medicinal and organic chemistry.